Skyhawk Therapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule therapies designed to modulate RNA targets, announces cUHDRS subcomponent data from the twelve-month ...
Morning Overview on MSN
Ultra-processed foods tracked to slower thinking even in people who otherwise eat well
Adults who eat more ultra-processed foods show measurably slower thinking on standardized cognitive tests, and the effect ...
On May 27, the American Cancer Society published updated screening guidelines for colorectal cancer, officially adding Guardant Health’s FDA-approved Shield blood test to its list of approved ...
Pilot study of whole-exome sequencing and single-nucleus RNA sequencing to identify actionable alterations in cancer. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting I. This ...
Cognitive impairment is increasingly recognized in patients with cerebral venous congestion (CVC), yet the cognitive tools used are largely adapted from stroke and dementia research. This review ...
Survival in Patients With Low Expression of Wild-Type Homologous Recombination Genes: Refining the Homologous Recombination Paradigm in Colorectal Cancer Among 556 patients with mNSCLC, 98.8% received ...
Background Cognitive impairment is common in multiple sclerosis (MS), and visual memory impairments are increasingly considered clinically important, yet still underappreciated. Objective To compare ...
A social media post from the US Food and Drug Administration this week shows a big-eyed macaque staring out from behind bars. “Some drugs use 144 monkeys on average for preclinical testing,” the post ...
Forbes contributors publish independent expert analyses and insights. Journalist, analyst, author, podcaster. This voice experience is generated by AI. Learn more. This voice experience is generated ...
Parkinson’s disease (PD) can be classified into brain-first and body-first subtypes based on the initial site of α-synuclein pathology. Postmortem studies further suggest that body-first PD may be ...
Depression and anxiety in patients with Huntington disease (HD) were associated with an increased risk for HD progression and all-cause mortality, but antidepressant initiation was linked to a reduced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results